Community/Retail

The study found patients who were prescribed antibiotics for dental procedures tended to be older and more likely to receive clindamycin, an antibiotic that is associated with C diff infection.

FDA officials have approved an 80-mg capsule strength of Neurocrine Biosciences’ valbenazine (Ingrezza) for the treatment of adults with tardive dyskinesia (TD), the company announced in a press release

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

FDA officials have approved onabotulinumtoxinA (BOTOX Cosmetic, Allergan) for its third indication for the temporary improvement in the appearance of moderate-to-severe forehead lines associated with frontalis muscle activity in adults.

According to an "FDA in Brief" report, officials with the FDA received an adverse event report on August 14, 2017, from a physician concerning a patient who was diagnosed postoperatively with bilateral hemorrhagic occlusive retinal vasculitis (HORV).

On September 29, 2017, the ASHP (American Society of Health-System Pharmacists) Board of Directors voted unanimously to approve the creation of an enhanced membership home for pharmacy technicians — the ASHP Pharmacy Technician Forum.

The Drug Quality and Security Act (DQSA) provides a framework for working with outsourcing facilities to meet federal regulatory standards.